115 related articles for article (PubMed ID: 28595277)
1. Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72.
Baek JY; Chung DR; Ko KS; Kim SH; Yang SJ; Kang CI; Peck KR; Song JH
J Antimicrob Chemother; 2017 Sep; 72(9):2454-2460. PubMed ID: 28595277
[TBL] [Abstract][Full Text] [Related]
2. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
[TBL] [Abstract][Full Text] [Related]
3. Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300.
Gardete S; Kim C; Hartmann BM; Mwangi M; Roux CM; Dunman PM; Chambers HF; Tomasz A
PLoS Pathog; 2012 Feb; 8(2):e1002505. PubMed ID: 22319446
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
5. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
6. First report of vancomycin-intermediate resistance in sequence type 72 community genotype methicillin-resistant Staphylococcus aureus.
Chung DR; Baek JY; Kim HA; Lim MH; Kim SH; Ko KS; Kang CI; Peck KR; Lee NY; Song JH
J Clin Microbiol; 2012 Jul; 50(7):2513-4. PubMed ID: 22553243
[TBL] [Abstract][Full Text] [Related]
7. Role of stop codons in development and loss of vancomycin non-susceptibility in methicillin-resistant Staphylococcus aureus.
Doddangoudar VC; O'Donoghue MM; Chong EY; Tsang DN; Boost MV
J Antimicrob Chemother; 2012 Sep; 67(9):2101-6. PubMed ID: 22643192
[TBL] [Abstract][Full Text] [Related]
8. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G
Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723
[TBL] [Abstract][Full Text] [Related]
9. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
Asadpour L; Ghazanfari N
Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina.
Sola C; Lamberghini RO; Ciarlantini M; Egea AL; Gonzalez P; Diaz EG; Huerta V; Gonzalez J; Corso A; Vilaro M; Petiti JP; Torres A; Vindel A; Bocco JL
Ann Clin Microbiol Antimicrob; 2011 Apr; 10():15. PubMed ID: 21527033
[TBL] [Abstract][Full Text] [Related]
11. Emergence of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Clinical Isolates Among Daptomycin-Naive Patients in Korea.
Nam EY; Yang SJ; Kim ES; Cho JE; Park KH; Jung SI; Yoon N; Kim DM; Lee CS; Jang HC; Park Y; Lee KS; Kwak YG; Lee JH; Park SY; Hwang JH; Kim M; Song KH; Kim HB
Microb Drug Resist; 2018 Jun; 24(5):534-541. PubMed ID: 29863982
[TBL] [Abstract][Full Text] [Related]
12. VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.
Mehta S; Cuirolo AX; Plata KB; Riosa S; Silverman JA; Rubio A; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Jan; 56(1):92-102. PubMed ID: 21986832
[TBL] [Abstract][Full Text] [Related]
13. Draft genome sequence of reduced teicoplanin-susceptible and vancomycin-heteroresistant methicillin-resistant Staphylococcus aureus from sepsis cases.
Bakthavatchalam YD; Veeraraghavan B; Devanga Ragupathi NK; Babu P; Munuswamy E; David T
J Glob Antimicrob Resist; 2017 Mar; 8():169-171. PubMed ID: 28216019
[TBL] [Abstract][Full Text] [Related]
14. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
Mirza HC; Sancak B; Gür D
Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
[TBL] [Abstract][Full Text] [Related]
16. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
Chen CJ; Lin MH; Shu JC; Lu JJ
J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
[TBL] [Abstract][Full Text] [Related]
17. VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus.
Boyle-Vavra S; Yin S; Jo DS; Montgomery CP; Daum RS
Antimicrob Agents Chemother; 2013 Jan; 57(1):83-95. PubMed ID: 23070169
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
19. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
[TBL] [Abstract][Full Text] [Related]
20. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
